Recent News

Do Common Prostate Cancer Treatments Cause Cognitive Decline?

EAU21: Active Surveillance Versus Treatment for Older Men With Low-Risk Prostate Cancer

Comparing Imaging Modalities After Prostatectomy to Guide Radiotherapy Decision-Making

Phase II Study of Bipolar Androgen Therapy and Nivolumab in Prostate Cancer

Early Results With PSMA-Targeting T-Cell Engager in Metastatic Prostate Cancer

ASCO 2021: Prostate Cancer Treatment Disparities During First Wave of COVID-19 Pandemic

ASCO 2021: Bone-Protecting Agents With Enzalutamide Treatment for Metastatic Prostate Cancer

FDA Brief: Radioligand Therapy Receives Breakthrough Therapy Designation in Prostate Cancer

Long-Terms Results With Apalutamide Plus ADT in Metastatic Prostate Cancer

ASCO 2021: Early-Phase Study of Alpha Emitter in Castration-Resistant Prostate Cancer

ASCO 2021: ADT Plus Novel Targeted Therapy in Metastatic Prostate Cancer

Risk of Cardiovascular Events Following Hormone Therapy for Prostate Cancer

ASCO 2021: PEACE-1 Trial of Abiraterone-Based Combination Therapy in Metastatic Prostate Cancer

ASCO 2021: Radiolabeled Antibody Plus Standard of Care for PSMA-Positive Prostate Cancer

Sleep Quality and Depression in Men With Prostate Cancer

First PSMA PET Imaging Agent for Prostate Cancer Approved by FDA

Role of ERβ and EGFR in Prostate Cancer: Therapeutic Implications

ASCO 2021: Does PSA Screening Intensity Impact Outcomes in Younger Black Men With Prostate Cancer?

Kidney Health With Androgen-Deprivation Therapy for Prostate Cancer

Can Waist Circumference and Body Shape Index Influence the Risk of Prostate Cancer?

Molecular and Genomic Differences in Prostate Cancer: Impact on Racial Disparities in Treatment

Is Adding Palbociclib to Androgen-Deprivation Therapy of Benefit in Prostate Cancer?

Localized Intermediate-Risk Prostate Cancer: MRI-Guided Focused Ultrasound Ablation

AACR 2021: Exploratory Analysis of Molecular Signatures From TITAN Trial in Prostate Cancer

AACR 2021: Is the B7-H3 Protein an Actionable Target in Prostate Cancer?

AACR 2021: Prostate Cancer Risk, Obesity, and Diabetes

AACR 2021: Role of a Healthy Lifestyle in Offsetting Genetic Risks for Prostate Cancer

Cardiovascular Risk Factors and Prostate Cancer in U.S. Veterans

AACR 2021: Nivolumab Plus Ipilimumab in Biomarker-Selected Patients With Metastatic Prostate Cancer

Are Antiepileptic Drugs Linked to Reduced Risk of Prostate Cancer?

Urologists’ Attitudes About Active Surveillance for Low-Risk Prostate Cancer: Survey Findings

Phase III Trial Update on Ipatasertib Plus Abiraterone in Metastatic Prostate Cancer

Can White Button Mushroom Extract Slow the Growth of Prostate Cancer?

Erectile Dysfunction and Sexual Satisfaction After Robot-Assisted Radical Prostatectomy

Nivolumab Plus Docetaxel for Metastatic Castration-Resistant Prostate Cancer

Active Surveillance for Low-Risk Prostate Cancer: Practice Variation by Geographic Location

KEYNOTE-365 Update on Pembrolizumab Plus Chemotherapy for Metastatic Prostate Cancer

Novel Protein Inhibitor CCS1477 Under Study in Treatment-Resistant Prostate Cancer

Are Genetic Factors Potentially Driving Prostate Cancer in Black Individuals?

GU Symposium 2021: Adding Pembrolizumab to Radium-223 for Metastatic Castration-Resistant Prostate Cancer

Taking on Prostate Cancer and Myeloma: A Man Named Steele

GU Symposium 2021: Novel Tool for Predicting Metastasis After Radiotherapy for Prostate Cancer

GU Symposium 2021: Dose-Intensified Approach to Salvage Radiotherapy in Biochemically Recurrent Prostate Cancer

$3.8 Million Donation to Mount Sinai to Support Accessibility to Prostate Cancer Screening for Black Men

GU Symposium 2021: Final TITAN Trial Results in Metastatic Prostate Cancer

Delays in Radical Prostatectomy: Oncologic Outcomes in High-Risk Prostate Cancer

GU Symposium 2021: Final ACIS Results on Apalutamide-Based Therapy for Metastatic Prostate Cancer

GU Symposium 2021: Results From the Biomarker Cohort of the Phase III SPARTAN Trial

GU Symposium 2021: Does Less PSA Screening Mean More Metastatic Prostate Cancer?

Is Extended Pelvic Lymph Node Dissection Associated With Perioperative Complications?

Radical Prostatectomy Versus Radiotherapy for Localized Ductal Prostate Cancer